Gongwin Biopharm Holdings Co., Ltd. (TPEX:6617)
100.00
-2.50 (-2.44%)
Jun 16, 2025, 12:57 PM CST
Gongwin Biopharm Holdings Market Cap
Gongwin Biopharm Holdings has a market cap or net worth of 12.77 billion as of June 13, 2025. Its market cap has decreased by -40.05% in one year.
Market Cap
12.77B
Enterprise Value
10.88B
Revenue
34.23M
Ranking
n/a
PE Ratio
n/a
Stock Price
100.00
Market Cap Chart
Since February 8, 2017, Gongwin Biopharm Holdings's market cap has increased from 8.87B to 12.77B, an increase of 44.06%. That is a compound annual growth rate of 4.47%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
PharmaEssentia | 179.30B |
Caliway Biopharmaceuticals | 154.14B |
Bora Pharmaceuticals Co., LTD. | 83.48B |
Lotus Pharmaceutical | 57.19B |
Oneness Biotech | 36.59B |
Polaris Group | 30.82B |
Lumosa Therapeutics | 27.77B |
Center Laboratories | 27.39B |